A prospective evaluation of the analytical performance of GENECUBE® HQ SARS-CoV-2 and GENECUBE® FLU A/B
Yoshihiko Kiyasu, View ORCID ProfileYusaku Akashi, Akio Sugiyama, Yuto Takeuchi, Shigeyuki Notake, Asami Naito, Koji Nakamura, Hiroichi Ishikawa, Hiromichi Suzuki
doi: https://doi.org/10.1101/2021.02.24.21252337
Yoshihiko Kiyasu
1Department of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, Japan
Yusaku Akashi
2Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki 305-8558, Japan
3Akashi Internal Medicine Clinic, 3-1-63 Asahigaoka, Kashiwara, Osaka 582-0026, Japan
Akio Sugiyama
4Diagnostic System Department, TOYOBO Co., Ltd., 2-2-8, Dojima Hama, Kita-ku, Osaka, 530-8230, Japan
Yuto Takeuchi
1Department of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, Japan
2Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki 305-8558, Japan
Shigeyuki Notake
5Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki 305-8558, Japan
Asami Naito
6Tsukuba i-Laboratory LLP, 2-1-17, Amakubo, Tsukuba, Ibaraki, 305-0005 Japan
Koji Nakamura
5Department of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki 305-8558, Japan
Hiroichi Ishikawa
7Department of Respiratory Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki 305-8558, Japan
Hiromichi Suzuki
2Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki 305-8558, Japan
8Department of Infectious Diseases, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
Article usage
Posted February 25, 2021.
A prospective evaluation of the analytical performance of GENECUBE® HQ SARS-CoV-2 and GENECUBE® FLU A/B
Yoshihiko Kiyasu, Yusaku Akashi, Akio Sugiyama, Yuto Takeuchi, Shigeyuki Notake, Asami Naito, Koji Nakamura, Hiroichi Ishikawa, Hiromichi Suzuki
medRxiv 2021.02.24.21252337; doi: https://doi.org/10.1101/2021.02.24.21252337
A prospective evaluation of the analytical performance of GENECUBE® HQ SARS-CoV-2 and GENECUBE® FLU A/B
Yoshihiko Kiyasu, Yusaku Akashi, Akio Sugiyama, Yuto Takeuchi, Shigeyuki Notake, Asami Naito, Koji Nakamura, Hiroichi Ishikawa, Hiromichi Suzuki
medRxiv 2021.02.24.21252337; doi: https://doi.org/10.1101/2021.02.24.21252337
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (624)
- Anesthesia (162)
- Cardiovascular Medicine (2335)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11699)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3686)
- Geriatric Medicine (345)
- Health Economics (632)
- Health Informatics (2364)
- Health Policy (925)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (363)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3447)
- Nursing (194)
- Nutrition (520)
- Oncology (1801)
- Ophthalmology (533)
- Orthopedics (217)
- Otolaryngology (285)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6089)
- Radiology and Imaging (1256)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)